how long will semaglutide be on the shortage list As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The Ozempic Shortage Is Over

Semaglutide is typically initiated at a lower dose and gradually increased to minimize potential side effects

Clients are in weight loss, on average, for 12 weeks

The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo

To address these uncertainties, longer-term studies with larger and more globally diverse participant groups are necessary

One consequence of using this workaround to circumvent the rules governing Medicare Part D and weight-loss drugs: While eligibility for the Bridge program is restricted to people who currently have Medicare Part D (or a Medicare Advantage plan that includes drug coverage), the Bridge programs $50-per-month copays wont count toward the Part D out-of-pocket max, which is $2,100 in 2026

If you are struggling with your weight or health and have not tried dietary and lifestyle modifications first, these are a good starting point